Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Dittus

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Blood Reviews|June 26, 2022
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myelomaJeremy Meier, Jeffrey L Jensen, Christopher Dittus, et al.
Clinical Case Reports|October 19, 2019
Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature reviewJessica D Rich, Stephen M Clark, Yuri Fedoriw, et al.
Leukemia & Lymphoma|February 11, 2020
A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomasLuis Malpica, Bolanle Mufuka, Jonathan Galeotti, et al.
Ejhaem|September 2, 2022
A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virusChristopher Dittus, Natalie Grover, Tarsheen Sethi, et al.
Leukemia & Lymphoma|September 16, 2020
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphomaTyler Walburn, Natalie S Grover, Colette J Shen, et al.
Leukemia & Lymphoma|September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantationTimothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Journal for Immunotherapy of Cancer|August 1, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomasNicholas P Tschernia, Hillary Heiling, Allison M Deal, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Blood Reviews|June 26, 2022
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myelomaJeremy Meier, Jeffrey L Jensen, Christopher Dittus, et al.
Clinical Case Reports|October 19, 2019
Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature reviewJessica D Rich, Stephen M Clark, Yuri Fedoriw, et al.
Leukemia & Lymphoma|February 11, 2020
A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomasLuis Malpica, Bolanle Mufuka, Jonathan Galeotti, et al.
Ejhaem|September 2, 2022
A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virusChristopher Dittus, Natalie Grover, Tarsheen Sethi, et al.
Leukemia & Lymphoma|September 16, 2020
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphomaTyler Walburn, Natalie S Grover, Colette J Shen, et al.
Leukemia & Lymphoma|September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantationTimothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Blood|January 30, 2019
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphomaPeter Martin, Nancy L Bartlett, Kristie A Blum, et al.
Journal for Immunotherapy of Cancer|August 1, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomasNicholas P Tschernia, Hillary Heiling, Allison M Deal, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Pageof 4